1. |
Zeng Q, Chen S, You Z, et al. Hepatocyte growth factor inhibits anoikis in head and neck squamous cell carcinoma cells by activation of ERK and Akt signaling independent of NFκB [J]. J Biol Chem, 2002; 277(28): 2520325208.
|
2. |
Jass JR, Atkin WS, Cuzick J, et al. The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases [J]. Histopathology, 1986; 10(5): 437459.
|
3. |
Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual [M]. 6th edition. New York: SpringerVerlag, 2002: 143164.
|
4. |
Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: A new significant and independent prognostic indicator in earlystage breast carcinoma [J]. J Natl Cancer Inst, 1992; 84(24): 18751887.
|
5. |
Fromowitz FB, Voila MV, Chao S, et al. ras p21 expression in the progression of breast cancer [J]. Hum Pathol, 1987; 18(12): 12681275.
|
6. |
涂小煌, 王为忠, 王烈, 等. 直肠癌及其远端黏膜p53和CD34的表达及意义 [J]. 中国普外基础与临床杂志, 2008; 15(9): 641645.
|
7. |
Yu JX, Cui L, Zhang QY, et al. Expression of NOS and HIF1α in human colorectal carcinoma and implication in tumor angiogenesis [J]. World J Gastroenterol, 2006; 12(29): 46604664.
|
8. |
于建宪, 崔琳, 张七一, 等. 组织芯片检测大肠癌中NOS、HIF1α表达及与血管生成的关系 [J]. 病理诊断学杂志, 2007; 14(1): 4447.
|
9. |
Nakamura T, Nishizawa T, Hagiya M, et al. Molecular cloning and expression of human hepatocyte growth factor [J]. Nature, 1989; 342(6248): 440443.
|
10. |
Stoker M, Gherardi E, Perryman M, et al. Scatter factor is a fibroblastderived modulator of epithelial cell mobility [J]. Nature, 1987; 327(6119): 239242.
|
11. |
Gherardi E, Stoker M. Hepatocytes and scatter factor [J]. Nature, 1990; 346(6281): 228.
|
12. |
Miyazawa K, Tsubouchi H, Naka D, et al. Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor [J]. Biochem Biophys Res Commun, 1989; 163(2): 967973.
|
13. |
Rosenthal EL, Johnson TM, Allen ED, et al. Role of the plasminogen activator and matrix metalloproteinase systems in epidermal growth factor and scatter factorstimulated invasion of carcinoma cells [J]. Cancer Res, 1998; 58(22): 52215230.
|
14. |
魏松锋, 高明, 于洋, 等. HGF、CXCR4、VEGFD表达与甲状腺乳头状癌颈淋巴结转移的关系 [J]. 现代肿瘤医学, 2008; 16(8): 12951297.
|
15. |
Horiguchi N, Takayama H, Toyoda M, et al. Hepatocyte growth factor promotes hepatocarcinogenesis through cMet autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamine [J]. Oncogene, 2002; 21(12): 17911799.
|
16. |
Cooper CS, Park M, Blair DG, et al. Molecular cloning of a new transforming gene from a chemically transformed human cell line [J]. Nature, 1984; 311(5981): 2933.
|
17. |
Park M, Dean M, Cooper CS, et al. Mechanism of met oncogene activation [J]. Cell, 1986; 45(6): 895904.
|
18. |
Bottaro DP, Rubin JS, Faletto DL, et al. Identification of the hepatocyte growth factor receptor as the cmet protooncogene product [J]. Science, 1991; 251(4995): 802804.
|
19. |
Ma PC, Maulik G, Christensen J, et al. cMet: structure, functions and potential for therapeutic inhibition [J]. Cancer Metastasis Rev, 2003; 22(4): 309325.
|
20. |
Liu C, Park M, Tsao MS. Overexpression of cmet protooncogene but not epidermal growth factor receptor or cerbB2 in primary human colorectal carcinomas [J]. Oncogene, 1992; 7(1): 181185.
|
21. |
Takeuchi H, Bilchik A, Saha S, et al. cMET expression level in primary colon cancer: a predictor of tumor invasion and lymph node metastases [J]. Clin Cancer Res, 2003; 9(4): 14801488.
|
22. |
Kermorgant S, Aparicio T, Dessirier V, et al. Hepatocyte growth factor induces colonic cancer cell invasiveness via enhanced motility and protease over production. Evidence for PI3 kinase and PKC involvement [J]. Carcinogenesis, 2001; 22(7): 10351042.
|
23. |
Xie Q, Liu KD, Hu MY, et al. SF/HGFcMet autocrine and paracrine promote metastasis of hepatocellular carcinoma [J]. World J Gastroenterol, 2001; 7(6): 816820.
|
24. |
李可洲, 伍晓汀, 李宁, 等. 肝细胞生长因子对大鼠移植小肠粘膜结构的保护作用 [J]. 中国普外基础与临床杂志, 2003; 10(3): 236239.
|
25. |
Qian CN, Guo X, Cao B, et al. Met protein expression level correlates with survival in patients with latestage nasopharyngeal carcinoma [J]. Cancer Res, 2002; 62(2): 589596.
|
26. |
Edakuni G, Sasatomi E, Satoh T, et al. Expression of the hepatocyte growth factor/cMet pathway is increased at the cancer front in breast carcinoma [J]. Pathol Int, 2001; 51(3): 172178.
|
27. |
Maulik G, Shrikhande A, Kijima T, et al. Role of the hepatocyte growth factor receptor cMet, in oncogenesis and potential for therapeutic inhibition [J]. Cytokine Growth Factor Rev, 2002; 13(1): 4159.
|
28. |
Royal I, LamarcheVane N, Lamorte L, et al. Activation of cdc42, rac, PAK, and rhokinase in response to hepatocyte growth factor differentially regulates epithelial cell colony spreading and dissociation [J]. Mol Biol Cell, 2000; 11(5): 17091725.
|
29. |
张春旭, 王强, 李延甫, 等. cmet蛋白在高细胞变异型甲状腺乳头状癌中的表达 [J]. 中国普外基础与临床杂志, 2008; 15(5): 318322.
|
30. |
李宏武, 单吉贤. HGF/SF对姜黄素诱导大肠癌细胞凋亡的作用 [J]. 中国普外基础与临床杂志, 2006; 13(1): 7476.
|
31. |
Maulik G, Kijima T, Ma PC, et al. Modulation of the cMet/hepatocyte growth factor pathway in small cell lung cancer [J]. Clin Cancer Res, 2002; 8(2): 620627.
|
32. |
Dong G, Chen Z, Li ZY, et al. Hepatocyte growth factor/scatter factorinduced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin8 and vascular endothelial growth factor in head and neck squamous cell carcinoma [J]. Cancer Res, 2001; 61(15): 59115918.
|
33. |
Nakajima M, Sawada H, Yamada Y, et al. The prognostic significance of amplification and overexpression of cmet and cerbB2 in human gastric carcinomas [J]. Cancer, 1999; 85 (9): 18941902.
|
34. |
Chen BK, Ohtsuki Y, Furihata M, et al. Overexpression of cMet protein in human thyroid tumors correlated with lymph node metastasis and clinicopathologic stage [J]. Pathol Res Pract, 1999; 195(6): 427433.
|
35. |
Birchmeier C, Birchmeier W, Gherardi E, et al. Met, metastasis, motility and more [J]. Nat Rev Mol Cell Biol, 2003; 4(12): 915925.
|
36. |
陈碧华, 谢倩, 刘康达. CMet信号阻断对肝癌细胞生长和运动能力的影响 [J]. 中华肝脏病杂志, 2003; 11(8): 487489.
|
37. |
Herynk MH, Stoeltzing O, Reinmuth N, et al. Downregulation of cMet inhibits growth in the liver of human colorectal carcinoma cells [J]. Cancer Res, 2003; 63(11): 29902996.
|